Connect with us

Technology

Tecsys Reports Financial Results for the Second Quarter of Fiscal 2025

Published

on

SaaS revenue up 34% as ARR passes $100 million

MONTREAL, Dec. 4, 2024 /CNW/ — Tecsys Inc. (TSX: TCS), an industry-leading supply chain management SaaS company, today announced its results for the second quarter of fiscal 2025, ended October 31, 2024. All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards (IFRS).

“Tecsys delivered strong second-quarter results, marked by major milestones in our SaaS business,” said Peter Brereton, president and CEO at Tecsys. “We crossed some key thresholds as RPO surpassed $200 million and ARR exceeded $100 million, demonstrating the strength of our SaaS strategy and the trust our customers place in us. We are seeing the positive impact of our investments in innovation and customer success, positioning us well to capitalize on emerging opportunities.”

Mark Bentler, chief financial officer of Tecsys Inc., added, “Our fiscal 2025 financial performance reflects steady progress across key metrics, with year-to-date SaaS bookings up 20% over last year and our SaaS margins continuing to improve as we scale the business and continue to invest in platform optimization.” 

Second quarter highlights:

SaaS revenue increased by 34% to $16.1 million, up from $12.1 million in Q2 2024.SaaS subscription bookingsi (measured on an ARRi basis) were $3.7 million, flat compared to the second quarter of fiscal 2024.SaaS Remaining Performance Obligation (RPOi) increased by 39% to $203.8 million at October 31, 2024, up from $146.7 million at the same time last year.Total revenue increased to $42.4 million compared to $41.5 million in Q2 2024.Net profit was $0.8 million or $0.05 per share on a fully diluted basis in Q2 2025, compared to a net loss of $0.3 million or $0.02 per share for the same period in fiscal 2024.Adjusted EBITDAii was $2.9 million compared to $1.0 million reported in Q2 last year.In the second quarter of fiscal 2025, Tecsys acquired 51,600 of its outstanding common shares for approximately $2.1 million as part of its ongoing Normal Course Issuer Bid, compared to 25,800 shares acquired in the same period last year for approximately $0.7 million.

Year-to-date performance for first half of fiscal 2025

SaaS revenue increased by 33% to $31.4 million, up from $23.6 million in the same period of fiscal 2024.SaaS subscription bookingsi (measured on an ARRi basis) increased by 20% to $6.8 million, compared to $5.7 million in the same period of fiscal 2024.Total revenue increased to $84.7 million compared to $83.5 million in the same period of fiscal 2024.Net profit was $1.6 million ($0.11 per basic share or $0.10 per fully diluted share) in the first half of fiscal 2025, compared to a net profit of $0.8 million ($0.06 per basic and fully diluted share) for the same period in fiscal 2024.Adjusted EBITDAii was $5.5 million compared to $4.2 million reported in the same period of fiscal 2024.In the first half of fiscal 2025, Tecsys acquired 111,200 of its outstanding common shares for approximately $4.3 million as part of its ongoing Normal Course Issuer Bid, compared to 25,800 shares acquired in the same period last year for $0.7 million.

Financial guidance:

Tecsys is maintaining FY25 guidance on SaaS revenue growth at 30-32% as well as FY25 and FY26 adjusted EBITDA margins at 8-9% and 10-11%, respectively. Based on the ongoing unpredictability of hardware revenue and a rapidly evolving business model that is impacting professional services, Tecsys is revising Fiscal 2025 total revenue guidance to roughly flat.

On December 4, 2024, the Company declared a quarterly dividend of $0.085 per share to be paid on January 3, 2025 to shareholders of record on December 18, 2024.

Pursuant to the Canadian Income Tax Act, dividends paid by the Company to Canadian residents are considered to be “eligible” dividends.

i See Key Performance Indicators in Management’s Discussion and Analysis of the Q2 2025 Financial Statements.

ii See Non-IFRS Performance Measures in Management’s Discussion and Analysis of the Q2 2025 Financial Statements

Q2 2025 Financial Results Conference Call
Date: December 5, 2024
Time: 8:30 a.m. ET
Phone number: 800-836-8184 or 646-357-8785
The call can be replayed until December 12, 2024, by calling:
888-660-6345 or 646-517-4150 (access code: 91117#)

About Tecsys

Tecsys is a global provider of advanced supply chain solutions. With a commitment to innovation and customer success, the company equips organizations with the essential software, technology and expertise needed for operational excellence and competitive advantage. Its cloud solutions serve a diverse range of industries, including healthcare, distribution and converging commerce, across multiple complex, regulated and high-volume markets. Built on the Itopia® low-code application platform, Tecsys’ offerings include enterprise resource planning, warehouse management, consolidated service management, distribution and transportation management, supply management at the point of use and order management solutions. Tecsys provides critical data insights and control across the supply chain, ensuring that organizations are agile, responsive and scalable.

Tecsys is publicly traded on the Toronto Stock Exchange under the ticker symbol TCS. For more about Tecsys and its solutions, please visit www.tecsys.com.

Forward Looking Statements

The statements in this news release relating to matters that are not historical fact are forward-looking statements that are based on management’s beliefs and assumptions. Such statements are not guarantees of future performance and are subject to a number of uncertainties, including but not limited to future economic conditions, the markets that Tecsys Inc. serves, the actions of competitors, major new technological trends, and other factors beyond the control of Tecsys Inc., which could cause actual results to differ materially from such statements. More information about the risks and uncertainties associated with Tecsys Inc.’s business can be found in the MD&A section of the Company’s annual report and the most recently filed annual information form. These documents have been filed with the Canadian securities commissions and are available on our website (www.tecsys.com) and on SEDAR+ (www.sedarplus.ca).

Copyright © Tecsys Inc. 2024. All names, trademarks, products, and services mentioned are registered or unregistered trademarks of their respective owners.

Non-IFRS Measures

Reconciliation of EBITDA and Adjusted EBITDA

EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before stock-based compensation and restructuring costs. The exclusion of interest expense, interest income, income taxes and restructuring costs eliminates the impact on earnings derived from non-operational activities and non-recurring items, and the exclusion of depreciation, amortization and stock-based compensation eliminates the non-cash impact of these items.

The Company believes that these measures are useful measures of financial performance without the variation caused by the impacts of the items described above and that could potentially distort the analysis of trends in our operating performance. In addition, they are commonly used by investors and analysts to measure a company’s performance, its ability to service debt and to meet other payment obligations, or as a common valuation measurement. Excluding these items does not imply that they are necessarily non-recurring. Management believes these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company’s operating results, underlying performance and future prospects in a manner similar to management. Although EBITDA and Adjusted EBITDA are frequently used by securities analysts, lenders and others in their evaluation of companies, they have limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS.

The reconciliation of EBITDA and Adjusted EBITDA to the most directly comparable IFRS measure is provided below.

Three months

ended October 31,

Six months

ended October 31,

Trailing 12 months

ended October 31,

(in thousands of CAD)

2024

2023

2024

2023

2024

2023

Net profit (loss) for the period

$

758

$

(340)

$

1,556

$

831

$

2,574

$

2,165

Adjustments for:

Depreciation of property and equipment and right-of-use assets

377

377

748

761

1,464

1,677

Amortization of deferred development costs

198

147

395

289

689

569

Amortization of other intangible assets

328

394

662

790

1,365

1,603

Interest expense

24

53

49

91

121

200

Interest income

(163)

(253)

(380)

(522)

(873)

(954)

Income taxes

427

(81)

863

778

726

1,988

EBITDA

$

1,949

$

297

$

3,893

$

3,018

$

6,066

$

7,248

Adjustments for:

Stock based compensation

993

724

1,640

1,176

2,765

2,169

Restructuring costs

–

–

–

–

2,122

–

Adjusted EBITDAii

$

2,942

$

1,021

$

5,533

$

4,194

$

10,953

$

9,417

 

Condensed Interim Consolidated Statements of Financial Position
(Unaudited)

(In thousands of Canadian dollars)

 

October 31, 2024

April 30, 2024

Assets

Current assets

Cash and cash equivalents

$

16,848

$

18,856

Short-term investments

11,496

16,713

Accounts receivable

21,846

22,090

Work in progress

4,498

4,248

Other receivables

375

134

Tax credits

8,704

6,422

Inventory

2,116

1,359

Prepaid expenses and other

8,227

9,143

Total current assets

74,110

78,965

Non-current assets

Other long-term receivables and assets

545

421

Tax credits

5,748

4,737

Property and equipment

1,255

1,372

Right-of-use assets

1,044

1,251

Contract acquisition costs

4,356

4,478

Deferred development costs

3,173

2,683

Other intangible assets

7,196

7,703

Goodwill

17,570

17,363

Deferred tax assets

9,073

9,073

Total non-current assets

49,960

49,081

Total assets

$

124,070

$

128,046

Liabilities

Current liabilities

Accounts payable and accrued liabilities

18,933

20,030

Deferred revenue

36,925

36,211

Lease obligations

834

812

Total current liabilities

56,692

57,053

Non-current liabilities

Other long-term accrued liabilities

568

496

Deferred tax liabilities

649

826

Lease obligations

890

1,302

Total non-current liabilities

2,107

2,624

Total liabilities

$

58,799

$

59,677

Equity

Share capital

$

52,628

$

52,256

Contributed surplus

6,970

9,417

Retained earnings

7,309

8,121

Accumulated other comprehensive loss

(1,636)

(1,425)

Total equity attributable to the owners of the Company

65,271

68,369

Total liabilities and equity

$

124,070

$

128,046

 

Condensed Interim Consolidated Statements of Income (loss) and Comprehensive Income (loss)
(Unaudited)

(In thousands of Canadian dollars, except per share data)

 

Three Months Ended

October 31,

Six Months Ended

October 31,

2024

2023

2024

2023

Revenue:

SaaS

$

16,130

$

12,072

$

31,444

$

23,567

Maintenance and Support

7,703

8,899

16,418

17,197

Professional Services

14,145

12,869

27,532

27,777

License

444

252

1,305

708

Hardware

4,020

7,397

8,019

14,215

Total revenue

42,442

41,489

84,718

83,464

Cost of revenue

21,994

23,144

44,542

45,619

Gross profit

20,448

18,345

40,176

37,845

Operating expenses:

Sales and marketing

9,052

8,645

17,404

16,316

General and administration

3,199

2,971

6,177

5,930

Research and development, net of tax credits

7,205

7,133

14,536

14,245

Total operating expenses

19,456

18,749

38,117

36,491

Profit (loss) from operations

992

(404)

2,059

1,354

Other income (costs)

193

(17)

360

255

Profit (loss) before income taxes

1,185

(421)

2,419

1,609

Income tax expense (benefit)

427

(81)

863

778

Net profit (loss)

$

758

$

(340)

$

1,556

$

831

Other comprehensive income (loss):

Effective portion of changes in fair value on designated revenue hedges

(513)

(5,573)

(533)

(3,000)

Exchange differences on translation of foreign  operations

165

92

322

(334)

Comprehensive income (loss)

$

410

$

(5,821)

$

1,345

$

(2,503)

Basic earnings (loss) per common share

$

0.05

$

(0.02)

$

0.11

$

0.06

Diluted earnings (loss) per common share

$

0.05

$

(0.02)

$

0.10

$

0.06

 

Condensed Interim Consolidated Statements of Cash Flows
(Unaudited)

(In thousands of Canadian dollars)

 

Three Months Ended

October 31,

Six Months Ended

October 31,

2024

2023

2024

2023

Cash flows from operating activities:

Net profit (loss)

$

758

$

(340)

$

1,556

$

831

Adjustments for:

Depreciation of property and equipment and right-of-use-assets

377

377

748

761

Amortization of deferred development costs

198

147

395

289

Amortization of other intangible assets

328

394

662

790

Interest (income) expense and foreign exchange (gain) loss

(193)

17

(360)

(255)

Unrealized foreign exchange and other

206

600

83

(598)

Non-refundable tax credits

(505)

(774)

(934)

(1,214)

Stock-based compensation

993

724

1,640

1,176

Income taxes

184

362

187

376

Net cash from operating activities excluding changes in non-cash working capital items related to operations

2,346

1,507

3,977

2,156

Accounts receivable

(2,132)

4,045

302

2,225

Work in progress

2,245

(1,390)

(241)

(2,219)

Other receivables and assets

84

214

(436)

(48)

Tax credits

(1,325)

(1,248)

(2,359)

(2,319)

Inventory

(40)

(242)

(754)

(1,084)

Prepaid expenses

60

(358)

963

(641)

Contract acquisition costs

119

137

80

140

Accounts payable and accrued liabilities

1,119

273

(2,000)

(3,293)

Deferred revenue

3,652

1,246

691

2,622

Changes in non-cash working capital items related to operations

3,782

2,677

(3,754)

(4,617)

Net cash provided by (used in) operating activities

6,128

4,184

223

(2,461)

Cash flows from financing activities:

Payment of lease obligations

(204)

(199)

(402)

(398)

Payment of dividends

(2,368)

(2,208)

(2,368)

(2,208)

Interest paid

(24)

(53)

(49)

(91)

Issuance of common shares on exercise of stock options

320

881

597

2,644

Shares repurchased and cancelled

(2,101)

(673)

(4,312)

(673)

Net cash used in financing activities

(4,377)

(2,252)

(6,534)

(726)

Cash flows from investing activities:

Interest received

3

33

27

69

Transfers from short-term investments

5,022

–

5,570

22

Acquisitions of property and equipment

(200)

(163)

(409)

(265)

Deferred development costs

(433)

(253)

(885)

(500)

Net cash provided by (used in) investing activities

4,392

(383)

4,303

(674)

Net increase (decrease) in cash and cash equivalents

    during the period

6,143

1,549

(2,008)

(3,861)

Cash and cash equivalents – beginning of period

10,705

15,825

18,856

21,235

Cash and cash equivalents – end of period

$

16,848

$

17,374

$

16,848

$

17,374

 

Condensed Interim Consolidated Statements of Changes in Equity 
(Unaudited)

(In thousands of Canadian dollars, except number of shares)

 

Share capital

Contributed
Surplus

 

Accumulated other
comprehensive
(loss) income

Retained
earnings

Total

Number

Amount

Balance, May 1, 2024

14,840,150

$

52,256

$

9,417

$

(1,425)

$

8,121

$

68,369

Net profit

–

–

–

–

1,556

1,556

Other comprehensive (loss) income:

Effective portion of changes in fair value on designated revenue hedges

–

–

–

(533)

–

(533)

Exchange difference on translation of foreign operations

–

–

–

322

–

322

Total comprehensive (loss) income

–

–

–

(211)

1,556

1,345

Shares repurchased and cancelled

(111,200)

(394)

(3,918)

–

–

(4,312)

Stock-based Compensation

–

–

1,640

–

–

1,640

Dividends to equity owners

–

–

–

–

(2,368)

(2,368)

Share options exercised

23,899

766

(169)

–

–

597

Total transactions with owners of the Company

(87,301)

$

372

(2,447)

$

–

$

(2,368)

$

(4,443)

Balance, October 31, 2024

14,752,849

$

52,628

$

6,970

$

(1,636)

$

7,309

$

65,271

Balance, May 1, 2023

14,582,837

$

44,338

15,285

$

(17)

$

10,832

$

70,438

Net profit

–

–

–

–

831

831

Other comprehensive income:

–

Effective portion of changes in fair value on designated revenue hedges

–

–

–

(3,000)

–

(3,000)

Exchange difference on translation of foreign operations

–

–

–

(334)

–

(334)

Total comprehensive (loss) income

–

–

–

(3,334)

831

(2,503)

Shares repurchased and cancelled

(25,800)

(84)

(589)

–

–

(673)

Stock-based Compensation

–

–

1,176

–

–

1,176

Dividends to equity owners

–

–

–

–

(2,208)

(2,208)

Share options exercised

161,249

3,388

(744)

–

–

2,644

Total transactions with owners of the Company

135,449

$

3,304

(157)

$

–

$

(2,208)

$

939

Balance, October 31, 2023

14,718,286

$

47,642

15,128

$

(3,351)

$

9,455

$

68,874

 

SOURCE Tecsys Inc.

Continue Reading

Technology

NUH WINS GOLD AT IHF AWARDS 2026 FOR GREEN OPERATING THEATRE PROGRAMME

Published

on

By

 NUH won Gold and received an Honourable Mention for its sustainability efforts at the International Hospital Federation Awards 2026, alongside presentations of its green surgical initiatives, digital health and organisational improvement initiatives at the World Hospital Congress.

SINGAPORE, Oct. 21, 2026 /PRNewswire/ — The National University Hospital (NUH) has won the Gold Award (Low Carbon Healthcare) for its Green Operating Theatre programme at the International Hospital Federation (IHF) Awards 2026. The hospital also received an Honourable Mention (Hospital Sustainability Acceleration) for its system-wide approach to embedding sustainability across healthcare delivery and hospital operations.

The awards were presented at the 49th World Hospital Congress in Seoul, where NUH is also sharing other initiatives in environmental sustainability, digital health and organisational improvement.

Professor Aymeric Lim, Chief Executive Officer of NUH, said: “Healthcare must become more sustainable without compromising patient care. Our teams have shown that simple, practical changes on the ground, from the way we run our operating theatres to how we use resources, can make a real difference. This recognition belongs to the multi-disciplinary teams and partners who turned ideas into everyday practice, and who continue to improve how we care for our patients.”

Advancing low-carbon healthcare by reducing the environmental impact of surgical care

NUH’s Green Operating Theatre (OT) programme began with efforts to reduce the use of high-carbon anaesthetic gases. What started as a targeted decarbonisation initiative has since grown into a hospital-wide programme that brings together clinicians, nurses, operations teams and facilities staff to drive sustainability across surgical practices, resource use, waste management and energy management.

The programme has achieved a 99 per cent reduction in the use of desflurane, a high-carbon anaesthetic gas, and delivered annual energy savings of about 660,000 kWh by optimising operating theatre ventilation during non-operating hours.

Surgical teams redesigned instrument sets used for high-volume knee replacement procedures to better reflect routine requirements, reducing emissions by almost 10,000 kg CO2e annually while also cutting water use and sterilisation workload. Efforts have also been made to reduce unnecessary consumables and expand medical recycling streams.

Collectively, these initiatives have generated valuable insights that NUH has actively shared through inter-cluster platforms and collaborations, helping to inform the adoption of low-carbon practices across Singapore’s public healthcare system.

Embedding sustainability into everyday healthcare delivery

NUH received an Honourable Mention for its organisation-wide approach to embedding sustainability into hospital planning and operations.

Guided by the IHF Sustainability Accelerator Tool, NUH integrated sustainability into leadership oversight, strategic planning and everyday decision-making, strengthening efforts in Appropriate Value-based Care, virtual care, procurement, workforce engagement and environmental stewardship.

This system-wide approach to advancing a sustainable healthcare system has been recognised internationally. In 2025, NUH became the first hospital worldwide to receive the Joint Commission International-Geneva Sustainability Centre’s Healthcare Sustainability Certification. This year, it was the only hospital in Singapore to be accorded the highest 5-Leaf distinction in Newsweek-Statista’s World’s Greenest Hospitals index.

A new model of rehabilitation care

Recognised as one of the top three healthcare innovations selected for the International Hospital Federation’s i-to-i Innovation Hub Awards 2026, the NUH Virtual Rehabilitation Centre (VRC) is helping to extend rehabilitation beyond hospital walls.

Developed as a virtual-first rehabilitation ecosystem, the VRC combines personalised patient education, self-management tools, AI-enabled telerehabilitation, remote monitoring and digital rehabilitation pathways to support patients throughout their recovery journey. By enabling rehabilitation to continue beyond traditional clinic visits, the VRC improves access to care, strengthens patient participation in recovery and allows therapists to focus their attention on patients with more complex rehabilitation needs. The digital home exercise programme, for instance, supports around 2,000 patients and records about 21,000 logins each month, freeing up the equivalent of 66 physiotherapist workdays annually for direct patient care.

The innovation demonstrates how technology can be used not simply to digitise existing services, but to transform how rehabilitation is delivered at scale.

Helping doctors work smarter with electronic medical records

NUH also presented results from its Great Epic Transformation (GET) programme at the 49th World Hospital Congress in Seoul. The hospital-wide programme trained specialist doctors to personalise their Epic electronic medical record (EMR) workflows, using customised note templates, order sets and shortcuts to work more efficiently.

Nine months after training, participating doctors spent 10.2 per cent less time in the EMR each day, equivalent to more than 33 hours saved per doctor annually, while time spent placing orders fell by 26.5 per cent. Twelve of 13 efficiency measures improved across both medical and surgical specialties. Based on annual estimates, the overall efficiency gains are valued at more than S$91 million a year.

The programme is being extended to allied health professionals and pharmacists across NUHS, with a target of reaching more than 2,000 healthcare professionals by the end of 2026.

About the National University Hospital (NUH)­

The National University Hospital (NUH) is Singapore’s university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.

Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.

We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.

The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg

Follow us on

Facebook | Instagram | LinkedIn | TikTok | YouTube

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuh-wins-gold-at-ihf-awards-2026-for-green-operating-theatre-programme-302916198.html

SOURCE National University Hospital (NUH)

Continue Reading

Technology

NEXCOM NGFW platforms secure growing traffic across modern academic networks

Published

on

By

TAIPEI, Oct. 21, 2026 /PRNewswire/ — NEXCOM, a leading supplier of network appliances, is helping academic institutions strengthen network security as digital learning expands across cloud platforms, AI-powered tools, remote access, and connected campus services.

As educational environments become more distributed, academic networks must support growing traffic and diverse connections while protecting sensitive data and maintaining reliable access to learning resources. NEXCOM’s Next-Generation Firewall (NGFW) platforms provide a centralized security layer for inspecting and controlling traffic across campus and remote environments.

Learn more about securing digital learning environments in the joint case study.

Centralized Security for Digital Learning

On campus, NGFW platforms can inspect traffic between academic networks and external resources as students and faculty access learning platforms and web services. For remote users, secure VPN connectivity supports authorized access to internal resources while enabling centralized security policies.

“Every new digital service in education adds value for students and educators, but it also adds traffic, connections, and another layer of security responsibility,” says Allan Chiu, VP of Networking and Communication Solutions at NEXCOM. “The challenge is making sure security keeps pace without slowing down the learning experience. NEXCOM’s NGFW platforms provide the performance and scalability needed to secure modern, highly distributed academic networks.”

Scalable Platforms for Network Security

NEXCOM’s portfolio provides scalable platforms for firewall, edge security, secure remote access, and demanding network security workloads. Key platforms include:

NSA 7160R: A 2U high-performance security platform powered by dual Intel® Xeon® Scalable processors, with eight PCIe 5.0 expansion slots and throughput of up to 1.6 Tbps.FTA 5190: A compact 1U edge server powered by Intel Xeon 6 SoC technology, designed for reliable connectivity and security at the network edge.

About NEXCOM

Founded in 1992 and headquartered in Taipei, Taiwan, NEXCOM is shaping the future of AI-powered networking with its software-defined solutions. Through its Network and Communication Solutions (NCS) unit, NEXCOM delivers cutting-edge platforms for Cybersecurity, OT Security, SD-WAN, SASE, Load Balancing, 5G uCPE, edge AI, and more. NCS specializes in professional design and manufacturing services, enabling reliable and scalable network infrastructures for businesses of all sizes. With a focus on innovation, NEXCOM’s solutions empower customers worldwide to build resilient, high-performance networks tailored to the demands of tomorrow’s connectivity challenges.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nexcom-ngfw-platforms-secure-growing-traffic-across-modern-academic-networks-302916203.html

SOURCE NEXCOM International Co., Ltd.

Continue Reading

Technology

Forrester’s 2027 B2B Go-To-Market Predictions: AI Agents Will Influence 75% Of B2B Purchase Decisions

Published

on

By

To remain competitive, providers must strengthen customer trust, substantiate value claims, and offer human expertise and guidance

SINGAPORE, Oct. 22, 2026 /PRNewswire/ — According to Forrester’s (Nasdaq: FORR) 2027 B2B go-to-market predictions, business buyers will increasingly deploy AI agents to handle tasks across the buying process, from supplier discovery and information gathering to contract-renewal analysis. While truly autonomous buying will remain concentrated in high-volume, low-risk, and repeatable purchases, the ubiquity of these agents will require providers to ensure that their systems and sellers can respond with speed, accuracy, and consistency.

Forrester’s B2B Predictions reports, covering topics including B2B go-to-market strategy, business buyers, and content and creative, offer forward-looking insights to help executives and their teams anticipate change, reduce uncertainty, and make confident decisions ahead of market shifts. Key highlights from the 2027 B2B go-to-market predictions include:

Buyers will double their human interactions to validate AI-generated recommendations. As AI becomes the primary interface for researching products and providers, buyers will encounter more AI-generated recommendations, synthetic content, automated outreach, and agent-mediated interactions. Since AI cannot fully judge service provider fit, feasibility, trust, or accountability, buyers will require conversations with provider teams and trusted third parties including analysts, customer references, and partners to confirm and validate buying decisions.Two-thirds of providers will lose deals because buyers cannot verify claims. Buyers already use AI-assisted search and analysis tools to gather information about products and vendors, synthesize provider claims, and fact check. As the reliance on these capabilities continue to advance, go-to-market teams will need to act fast to restructure content discovery for AI tools, including providing credible and consistent proof points that AI tools can index and validate.Most CMOs will cut programs or accept reduced capacity after overestimating AI gains. As pressure intensifies to reduce personnel costs with AI, marketing leaders will eliminate as many as 25% of roles in anticipation of productivity gains that fail to meet expectations. As a result, they will have to choose between cutting program budgets to restore capacity through rehiring, contractors, or agency support or accept reduced execution with a smaller team. In either case, lower campaign investment, weaker execution, or both will reduce marketing’s overall value contribution.

“In 2027, the defining challenge for B2B go-to-market leaders will be to make deliberate choices about what to automate and where human judgment still matters,” said Sharyn Leaver, chief research officer at Forrester. “As AI becomes ubiquitous across the buying process, B2B leaders that pair AI-driven speed and convenience with transparency, control, and trust will extract the most value from AI.”

Resources:

Download Forrester’s 2027 Predictions guide for B2B go-to-market.Register for Forrester’s webinar exploring the key trends reshaping B2B go-to-market strategies in 2027.Learn how to turn these predictions into action through Forrester’s global B2B events and research programs.

About Forrester
Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We empower leaders in technology, customer experience, digital, marketing, revenue, and product functions to make confident decisions in an AI-driven world and accelerate growth through customer obsession. Our unique research and continuous guidance model helps executives and their teams achieve their initiatives and outcomes faster and with confidence. To learn more, visit Forrester.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/forresters-2027-b2b-go-to-market-predictions-ai-agents-will-influence-75-of-b2b-purchase-decisions-302915245.html

SOURCE Forrester

Continue Reading

Trending